KUZU, M. Et Al. 2015. An Experience of Changing from Onabotulinumtoxn a to Abobotuliniumtoxin a in 64 Patient with Focal Hiperkinesias. 19th Internatioal Congress of Parkinson’xxs Disease and Movement Disorders , (San Diego) , 202-203.

KUZU, M., GÜL, İ. Ş., TEZCAN, S., & AKBOSTANCI, M. C., (2015). An Experience of Changing from Onabotulinumtoxn a to Abobotuliniumtoxin a in 64 Patient with Focal Hiperkinesias . 19th Internatioal Congress of Parkinson’xxs Disease and Movement Disorders (pp.202-203). San Diego

KUZU, MÜGE Et Al. "An Experience of Changing from Onabotulinumtoxn a to Abobotuliniumtoxin a in 64 Patient with Focal Hiperkinesias," 19th Internatioal Congress of Parkinson’xxs Disease and Movement Disorders, San Diego, 2015

KUZU, MÜGE K. Et Al. "An Experience of Changing from Onabotulinumtoxn a to Abobotuliniumtoxin a in 64 Patient with Focal Hiperkinesias." 19th Internatioal Congress of Parkinson’xxs Disease and Movement Disorders , San Diego, pp.202-203, 2015

KUZU, M. Et Al. (2015) . "An Experience of Changing from Onabotulinumtoxn a to Abobotuliniumtoxin a in 64 Patient with Focal Hiperkinesias." 19th Internatioal Congress of Parkinson’xxs Disease and Movement Disorders , San Diego, pp.202-203.

@conferencepaper{conferencepaper, author={MÜGE KUZU KUMCU Et Al. }, title={An Experience of Changing from Onabotulinumtoxn a to Abobotuliniumtoxin a in 64 Patient with Focal Hiperkinesias}, congress name={19th Internatioal Congress of Parkinson’xxs Disease and Movement Disorders}, city={San Diego}, country={}, year={2015}, pages={202-203} }